Search Results 21-30 of 27367 for Edith A. Perez

  1. Dados de estudos clínicos mundiais de dois medicamentos para câncer de mama HER2-positivo mostra que o trastuzumabe deve permanecer como o padrão de tratamento - Mayo Clinic News Network

    Edith Perez é copresidente do estudo “Otimização do Tratamento Adjuvante com ... O bloqueio duplo, usando dois medicamentos contra o HER2, apenas aumenta a ...

  2. Aziza Nassar, M.D., M.P.H. - Mayo Clinic Faculty Profiles

    ... Edith A. Perez, M.D., at Mayo Clinic, BC141410P1), Department of Defense (W81XWH-15-1-0293), September 2015-September 2024; Pathologist, A Phase 1b/2 Trial ...

  3. Olympic Runner Part of Mayo's Marathon History

    Samuelson, 51, began the race alongside Deegan and Edith Perez, M.D., oncologist and director of the Breast Center at Mayo Clinic's Florida campus. She ...

  4. Cancer - January 2020 Archives - Mayo Clinic News Network

    ... Perez shares perspective on new 'Stand Up To Cancer' Health Equity Initiative. Dr. Edith Perez, a Mayo Clinic oncologist and chair of the Stand Up To Cancer ...

  5. #FlashbackFriday 1996: Celebrating 10 years in Jacksonville - Mayo Clinic News Network

    Edith Perez; The ABZs of sleep disorders: Dr. Joseph Kaplan; Outdoor exercise in Florida: heat exhaustion and hydration: Dr. Walter Taylor. When Mayo Clinic ...

  6. EMBARGOED: Hold for release until Thursday, August 22, 2013 at 7:01 p.m. EDT Drug Used for Blood Cancers May Stop Spread of Brea

    The study's other key researchers at Mayo include Heike Doeppler, Edith Perez, M.D., Cathy. Andorfer, Ph.D., Zhifu Sun, M.D., Panos Anastasiadis, Ph.D., E ...

  7. Mayo Clinic researchers find new code that makes reprogramming of cancer cells possible

    Co-authors include Siu Ngok, Ph.D.; Ryan Feathers; Lomeli Carpio; Tiffany Baker; Jennifer Carr; Irene Yan; Sahra Borges, Ph.D.; Edith Perez, M.D. ...

  8. Estudo ALTTO sobre terapia combinada anti HER2, no Câncer de Mama, indica que um único agente, o Trastuzumabe, permanece como o padrão ouro de tratamento - Mayo Clinic News Network

    Edith Perez acrescenta que as descobertas também foram decepcionantes já que não confirmaram o beneficio de usar as duas terapias anti-HER2, que havia sido ...

  9. Em mais de oito anos de tratamento do câncer de mama HER2-positivo em estágio inicial, o trastuzumabe continua a apresentar benefícios para sobrevida das pacientes - Mayo Clinic News Network

    “Esse longo período de acompanhamento de pacientes mostra que, realmente, alteramos o curso natural dessa doença”, diz Edith Perez. “O Herceptin funciona ...

  10. Updated Testing Guidelines Make More Women Eligible for Herceptin, yet Benefit Uncertain

    Edith Perez, M.D., Mayo Clinic. The study was supported by grants from the National Cancer Institute of the National Institutes of Health. About the Mayo ...